Síndrome febril y lesión suprarrenal en paciente receptor de trasplante hepático

Revista Clinica Espanola

Volumn 198, Issue 10, 1998, Pages 690-700

  Quereda Navarro, C ^a   Navas Elorza, E ^a   Lopez San Roman A ^a   Moreno Caparros A ^a   Lumbreras Bermejo, C ^b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BLEEDING; CASE REPORT; CHRONIC HEPATITIS; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; FATALITY; HUMAN; LIVER TRANSPLANTATION; MALE; MILIARY TUBERCULOSIS; POSTOPERATIVE COMPLICATION; SPINE DISEASE;

AGED; FATAL OUTCOME; HEMORRHAGE; HEPATITIS, CHRONIC; HUMANS; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS; SPINAL DISEASES; TUBERCULOSIS, MILIARY;

EID: 0032193781     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Winston DJ, Emmanouilides C, Busuttil RW Infections in liver transplant recipients. Clin Infect Dis 1995. 21 1 077-1 091.
2. Kusne S, Dummer JS, Singh N, et al Infections after liver transplantation, an analysis of 101 consecutive cases. Medicine (Baltimore) 1988; 67:132-143
3. Paya CV, Hermans PE, Washington JA II. et al. Incidence, distribution, and outcome of episodes of infections in 100 orthotopic liver transplantation Mayo Clin Proc 1989. 64 555-564.
4. Singh N, Gayowski T, Wagener M, Yu VL. Infectious complications in liver transplant recipients on tacrolimus Transplantation 1994, 58 774-778
5. Chang FY, Singh N, Gayowski T, Wagener MM, Manno IR Fever in liver transplant recipients: changing spectrum of etiologic agents. Clin Infect Dis 1998. 26:59-65
6. Fishman JA, Rubin RH Infection in organ-transplant recipients. N Engl J Med 1998; 338:1 741-1 751
7. Gavaldà J, Pahissa A Factores de riesgo y cronología de la infección en el trasplante de órgano sólido Enferm Infecc Microbiol Clin 1997,15 (suppl 2):3-11
8. Garie EJ, Portman BC, Naoumov NV, et al Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996, 334:815-820
9. Lumbreras C, Colina F, Loinaz C, et al. Clinical, virological and histologic evolution of hepatitis C virus infection in liver transplant recipients. Clin Infect Dis 1998; 26.48-55.
10. Singh N, Gayowski T, Wagener MM, Marino IR. Increased infections in liver transplant recipients with recurrent hepatitis C virus hepatitis. Transplantation 1996, 61:402-406
11. Corell A, Morales JM, Mandrono A, et al. Immunosupression induced by hepatits C virus infection reduces acute renal transplant rejection Lancet 1995; 346:1.497-1 498
12. Danoff A Endocrinologic complications of HIV infection. Med Clin North Am 1996, 80 1.453-1 464.
13. Rubin RH, Tolkoff-Rubin NE Antimicrobial strategies in the care of organ transplant recipients Antimicrob Agents Chemother 1993, 37 619-624
14. Stratta RJ, Shaeffer MS, Markin RS, et al Cytomegalovirus infection and disease after liver transplantation Dig Dis Sci 1992; 37:673-688.
15. Singh N, Dummer JS, Kusne S, et al. Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis 1988; 158:124-131.
16. Paya CV, Wiesner RH, Hermans PE, et al. Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis. J Hepatol 1993; 18:185-195.
17. Álvarez C, Lumbreras C, Otero JR, Aguado JM, Lizasoain M, Moreno E, Noriega AR. Eficacia de la profilaxis anti-CMV limitada a los pacientes de «alto riesgo» en receptores de un trasplante de higado. VIII Congreso de la SEIMC Palma de Mallorca Mayo 1998. Resumen n.o 23-10
18. Rabella N, Péres JL, Pumarola T. El laboratorio de microbiología en la infección por citomegalovirus. Posibilidades actuales Enferm Infecc Microbiol Clin 1997, 15 (suppl 2):69-77.
19. Wade JJ, Rolando N, Hayllar K, Philipott-Howard J, Casewell MW, Williams R. Bacterial and fungal infections after liver transplantation. an analysis of 284 patients Hepatology 1995; 21.1.328-1.336.
20. Castaldo P, Stratta RJ, Wood RP, et al. Clinical spectrum of fungal infections after orthotopic liver transplantation. Arch Surg 1991, 126.149-156.
21. Miguélez M, Lumbreras C, Herrero JA, et al, Infección fúngica profunda en receptores de un trasplante de hígado Med Clín 1998; 110:406-410
22. Patel R, Portela D, Badley AD, et al Risk factors of invasive candida and non-candida infection after liver transplantation Transplantation 1996; 62 926-934.
23. Briegel J, Forst H, Spill B, et al. Risk factors for systemic fungal infections in liver transplant recipients Eur J Clin Microbiol Infect Dis 1995; 14.375-382
24. Singh N, Arnow PM, Bonham A, et al. Invasive aspergillosis in liver transplant recipients in the 1990s Transplantation 1997, 64:716-720.
25. Israelski DM, Remington JS Toxoplasmosis in the non-AIDS immunocompromised host En: Remington JS, Swartz MN, eds Current clinical topics in infectious diseases Boston (USA). Blackwell Sci Pubs. 1993, 13 322-329
26. Mayes AT, O'Connor BJ, Avery R, Castellani W, Carey W. Transmission of Toxoplasma gondin infection by liver transplantation. Clin Infect Dis 1995; 21 511-515
27. Hanto DW, Sakamoto K, Purtilo DT, Simmons RL, Najarian JS. The Epstein-Barr virus in the pathogenesis of postransplant lymphoproliferative disorders Surgery 1981 90 204-209
28. Penn I Postransplantation de novo tumors in liver allograft recipients Liver Transplantation and Surgery 1996; 2:52-59.
29. Walker RC, Paya CV, Marshall WF, et al. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantation. J Heart Lung Transplant 1995; 14:214-221.
30. Kuo PC, Dafoe DC, Alfrey EJ, Sibley RK, Scanding JD. Postransplant lymphoproliferative disrders and Epstein-Barr virus prophylaxis Transplantation 1995; 59:135-140.
31. Penn I. Kaposi's sarcoma in transplant recipients. Transplantation 1997; 64 669-673.
32. Aguado JM, Herrero JA, Gavaldà J, et al. Clinical presentation and outcome of tuberculosis in kidney, liver and heart transplant recipients in Spain. Transplantation 1997; 63:1.278-1 286
33. a ed). New York: Churchill Livingstone, 1994; 2.213-2 250.
34. Patel R, Roberts GD, Keating MR, Paya CV. Infections due to nontuberculous mycobacteria in kidney, heart and liver transplant recipients Clin Infect Dis 1994; 19:263-273.
35. Singh N, Gayowsk T, Marino IR, Schlichtig R. Acute adrenal insufficiency in critically ill lover transplant recipients. Implications for diagnosis. Transplantation 1995; 59:1.744-1 745.